Home > 106th Congressional Bills > H.R. 664 (ih) To provide for substantial reductions in the price of prescription drugs for Medicare beneficiaries. [Introduced in House] ...H.R. 664 (ih) To provide for substantial reductions in the price of prescription drugs for Medicare beneficiaries. [Introduced in House] ...
108th CONGRESS
1st Session
H. R. 663
To amend title IX of the Public Health Service Act to provide for the
improvement of patient safety and to reduce the incidence of events
that adversely affect patient safety, and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
February 11, 2003
Mr. Bilirakis (for himself, Mr. Brown of Ohio, Mr. Tauzin, Mr. Dingell,
Mr. Barton of Texas, Mr. Waxman, Mr. Upton, Mr. Markey, Mr. Greenwood,
Mr. Towns, Mr. Burr, Mr. Pallone, Mr. Whitfield, Mr. Gordon, Mr.
Norwood, Mr. Deutsch, Mr. Terry, Mr. Rush, Mr. Rogers of Michigan, Mr.
Engel, Mr. Wynn, Ms. McCarthy of Missouri, Mr. Strickland, Mrs. Capps,
Mr. John, and Ms. Harman) introduced the following bill; which was
referred to the Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To amend title IX of the Public Health Service Act to provide for the
improvement of patient safety and to reduce the incidence of events
that adversely affect patient safety, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Patient Safety and Quality
Improvement Act''.
SEC. 2. FINDINGS AND PURPOSES.
(a) Findings.--The Congress finds as follows:
(1) In 1999, the Institute of Medicine released a report
entitled ``To Err Is Human'' that described medical errors as
the 8th leading cause of death in the United States, with as
many as 98,000 people dying as a result of medical errors each
year.
(2) To address these deaths and injuries due to medical
errors, the health care system must identify and learn from
such errors so that systems of care can be improved.
(3) Myriad public and private patient safety initiatives
have begun. The Quality Interagency Coordination Task Force has
recommended steps to improve patient safety that may be taken
by each Federal agency involved in health care and activities
relating to these steps are ongoing.
(4) The Department of Health and Human Services has
initiated several patient safety projects. The Joint Commission
on Accreditation of Healthcare Organizations issued a patient
safety standard that went into effect on July 1, 2001, and the
peer review organizations are conducting ongoing studies of
clinical performance measurement of care delivered to
beneficiaries under the medicare program under title XVIII of
the Social Security Act.
(5) Several steps can be taken now to improve patient
safety. For example, according to the Centers for Disease
Control and Prevention, hand washing is the single most
important means of preventing the spread of infection. Repeated
studies indicate that lack of or improper hand washing still
contributes significantly to disease transmission in health
care settings. Working with experts from the private sector,
the Centers for Disease Control and Prevention has drafted
``Guidelines for Hand Hygiene in Healthcare Settings'' setting
forth recommendations to promote improved hand hygiene
practices and reduce transmission of pathogenic microorganisms
to patients and personnel in health care settings.
(6) According to the Centers for Disease Control and
Prevention, nosocomial infections affect approximately 2
million patients annually in acute care facilities in the
United States at an estimated direct patient care cost of
approximately $3.5 billion each year.
(7) The Congress encourages the continuation and
acceleration of private sector efforts to take immediate steps
to improve patient safety and recognizes the need for action in
the public sector to complement these efforts.
(8) The research on patient safety unequivocally calls for
a learning environment, where providers will feel safe to
report health care errors, in order to improve patient safety.
(9) Voluntary data gathering systems are more supportive
than mandatory systems in creating the learning environment
referred to in paragraph (8) as stated in the Institute of
Medicine's report.
(10) Promising patient safety reporting systems have been
established throughout the United States, and the best ways to
structure and use these systems are currently being determined,
largely through projects funded by the Agency for Healthcare
Research and Quality.
(11) Many organizations currently collecting patient safety
information have expressed a need for protections that will
allow them to review protected information so that they may
collaborate in the development and implementation of patient
safety improvement strategies. Currently, the State peer review
protections provide inadequate conditions to allow the sharing
of information to promote patient safety.
(12) In 2001, the Institute of Medicine released a report
entitled ``Crossing the Quality Chasm'' that found that the
United States health care system does not consistently deliver
high-quality care to patients.
(b) Purposes.--The purposes of this Act are--
(1) to encourage a culture of safety and quality in the
United States health care system by providing for a health care
errors reporting system that both protects information and
improves patient safety and quality of health care; and
(2) to ensure accountability by raising standards and
expectations for continuous quality improvements in patient
safety through the actions of the Secretary of Health and Human
Services.
SEC. 3. AMENDMENTS TO PUBLIC HEALTH SERVICE ACT.
(a) In General.--Title IX of the Public Health Service Act (42
U.S.C. 299 et seq.) is amended--
(1) in section 912(c), by inserting ``, in accordance with
part C,'' after ``The Director shall'';
(2) by redesignating part C as part D;
(3) by redesignating sections 921 through 928, as sections
931 through 938, respectively;
(4) in section 938(1) (as so redesignated), by striking
``921'' and inserting ``931''; and
(5) by inserting after part B the following:
``PART C--PATIENT SAFETY IMPROVEMENT
``SEC. 921. DEFINITIONS.
``In this part:
``(1) Identifiable information.--The term `identifiable
information' means information that is presented in a form and
manner that allows the identification of any provider, patient,
or reporter of patient safety work product. With respect to
patients, such information includes any individually
identifiable health information as that term is defined in the
regulations promulgated pursuant to section 264(c) of the
Health Insurance Portability and Accountability Act of 1996
(Public Law 104-191; 110 Stat. 2033).
``(2) Nonidentifiable information.--The term
`nonidentifiable information' means information that is
presented in a form and manner that prevents the identification
of any provider, patient, or reporter of patient safety work
product. With respect to patients, such information must be de-
identified consistent with the regulations promulgated pursuant
to section 264(c) of the Health Insurance Portability and
Accountability Act of 1996 (Public Law 104-191; 110 Stat.
2033).
``(3) Patient safety evaluation system.--The term `patient
safety evaluation system' means a process that involves the
collection, management, or analysis of information for
submission to or by a patient safety organization.
``(4) Patient safety organization.--The term `patient
safety organization' means a private or public organization or
component thereof that is certified, through a process to be
determined by the Secretary under section 925, to perform each
of the following activities:
``(A) The conduct, as the organization or
component's primary activity, of efforts to improve
patient safety and the quality of health care delivery.
``(B) The collection and analysis of patient safety
work product that is submitted by providers.
``(C) The development and dissemination of
evidence-based information to providers with respect to
improving patient safety, such as recommendations,
protocols, or information regarding best practices.
``(D) The utilization of patient safety work
product to carry out activities limited to those
described under this paragraph and for the purposes of
encouraging a culture of safety and of providing direct
feedback and assistance to providers to effectively
minimize patient risk.
``(E) The maintenance of confidentiality with
respect to identifiable information.
``(F) The provision of appropriate security
measures with respect to patient safety work product.
``(G) The submission of nonidentifiable information
to the Agency consistent with standards established by
the Secretary under section 923(b) for any National
Patient Safety Database.
``(5) Patient safety work product.--
``(A) The term `patient safety work product' means
any document or communication (including any
information, report, record, memorandum, analysis,
deliberative work, statement, or root cause analysis)
that--
``(i) except as provided in subparagraph
(B), is developed by a provider for the purpose
of reporting to a patient safety organization,
and is reported to a patient safety
organization;
``(ii) is created by a patient safety
organization; or
``(iii) would reveal the deliberations or
analytic process of a patient safety evaluation
system (as defined in paragraph (3)).
``(B)(i) Patient safety work product described in
subparagraph (A)(i)--
``(I) does not include any separate
information described in clause (ii); and
``(II) shall not be construed to include
such separate information merely by reason of
inclusion of a copy of the document or
communication involved in a submission to, or
the fact of submission of such a copy to, a
patient safety organization.
``(ii) Separate information described in this
clause is a document or communication (including a
patient's medical record or any other patient or
hospital record) that is developed or maintained, or
exists, separately from any patient safety evaluation
system.
``(C) Information available from sources other than
a patient safety work product under this section may be
discovered or admitted in a civil or administrative
proceeding, if discoverable or admissible under
applicable law.
``(6) Provider.--The term `provider' means--
``(A) an individual or entity licensed or otherwise
authorized under State law to provide health care
services, including--
``(i) a hospital, nursing facility,
comprehensive outpatient rehabilitation
facility, home health agency, and hospice
program;
``(ii) a physician, physician assistant,
nurse practitioner, clinical nurse specialist,
certified nurse midwife, psychologist,
certified social worker, registered dietitian
or nutrition professional, physical or
occupational therapist, or other individual
health care practitioner;
``(iii) a pharmacist; and
``(iv) a renal dialysis facility,
ambulatory surgical center, pharmacy, physician
or health care practitioner's office, long-term
care facility, behavioral health residential
treatment facility, clinical laboratory, or
community health center; or
``(B) any other person or entity specified in
regulations by the Secretary after public notice and
comment.
``SEC. 922. PRIVILEGE FOR PATIENT SAFETY WORK PRODUCT.
``(a) Privilege.--Notwithstanding any other provision of law and
subject to subsection (c), patient safety work product shall not be--
``(1) subject to a civil or administrative subpoena or
order;
``(2) subject to discovery in connection with a civil or
administrative proceeding;
``(3) subject to disclosure pursuant to section 552 of
title 5, United States Code (commonly known as the Freedom of
Information Act), or any other similar Federal or State law;
``(4) required to be admitted as evidence or otherwise
disclosed in any State or Federal civil or administrative
proceeding; or
``(5) if the patient safety work product is identifiable
information and is received by a national accreditation
organization in its capacity as a patient safety organization--
``(A) used by a national accreditation organization
in an accreditation action against the provider that
reported the information;
``(B) shared by such organization with its survey
team; or
``(C) required as a condition of accreditation by a
national accreditation association.
``(b) Reporter Protection.--
``(1) In general.--A provider may not use against an
individual in an adverse employment action described in
paragraph (2) the fact that the individual in good faith
reported information--
``(A) to the provider with the intention of having
the information reported to a patient safety
organization; or
``(B) directly to a patient safety organization.
``(2) Adverse employment action.--For purposes of this
subsection, an `adverse employment action' includes--
``(A) the failure to promote an individual or
provide any other employment-related benefit for which
the individual would otherwise be eligible;
``(B) an adverse evaluation or decision made in
relation to accreditation, certification,
credentialing, or licensing of the individual; and
``(C) a personnel action that is adverse to the
Other Popular 106th Congressional Bills Documents:
|
| GovRecords.org presents information on various agencies of the United States Government. Even though all information is believed to be credible and accurate, no guarantees are made on the complete accuracy of our government records archive. Care should be taken to verify the information presented by responsible parties. Please see our reference page for congressional, presidential, and judicial branch contact information. GovRecords.org values visitor privacy. Please see the privacy page for more information. |

![]() |